Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Commun (Camb) ; 53(56): 7890-7893, 2017 Jul 11.
Article in English | MEDLINE | ID: mdl-28597902

ABSTRACT

A convenient and effective synthetic access to chelating azides was designed enabling the preparation of efficient clickable fluorescent derivatives. The comparison of the reactivity of these chelating azides to regular azides showcased the striking superiority of such derivatives for labeling applications.

2.
J Labelled Comp Radiopharm ; 59(4): 175-86, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26991121

ABSTRACT

The 24th annual symposium of the International Isotope Society's United Kingdom Group took place at the Møller Centre, Churchill College, Cambridge, UK on Friday 6th November 2015. The meeting was attended by 77 delegates from academia and industry, the life sciences, chemical, radiochemical and scientific instrument suppliers. Delegates were welcomed by Dr Ken Lawrie (GlaxoSmithKline, UK, chair of the IIS UK group). The subsequent scientific programme consisted of oral presentations, short 'flash' presentations in association with particular posters and poster presentations. The scientific areas covered included isotopic synthesis, regulatory issues, applications of labelled compounds in imaging, isotopic separation and novel chemistry with potential implications for isotopic synthesis. Both short-lived and long-lived isotopes were represented, as were stable isotopes. The symposium was divided into a morning session chaired by Dr Rebekka Hueting (University of Oxford, UK) and afternoon sessions chaired by Dr Sofia Pascu (University of Bath, UK) and by Dr Alan Dowling (Syngenta, UK). The UK meeting concluded with remarks from Dr Ken Lawrie (GlaxoSmithKline, UK).

3.
Psychiatry Res ; 78(1-2): 45-50, 1998 Mar 20.
Article in English | MEDLINE | ID: mdl-9579701

ABSTRACT

Cholecystokinin (CCK), beta-endorphin (BE), and vasoactive intestinal peptide (VIP) in peripheral blood mononuclear cells from 30 drug-naive schizophrenics compared to 22 healthy controls were studied. Patients were evaluated with the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of the Negative Symptoms (SANS) at baseline (TO), and after four weeks (T4) in nine patients who were subsequently treated with haloperidol (HL). Neuropeptide concentrations in peripheral blood mononuclear cells (PBMC) were measured at TO and, for the treated patients, at T4. There was a negative correlation between CCK and SANS baseline scores and a trend for patients who responded poorly to HL (i.e. patients with a prevalence of negative symptomatology) to have lower CCK basal values.


Subject(s)
Antipsychotic Agents/pharmacology , Haloperidol/pharmacology , Leukocytes, Mononuclear/drug effects , Neuropeptides/drug effects , Schizophrenia/drug therapy , Adolescent , Adult , Analysis of Variance , Antipsychotic Agents/therapeutic use , Behavioral Symptoms/classification , Case-Control Studies , Chi-Square Distribution , Cholecystokinin/blood , Cholecystokinin/drug effects , Female , Haloperidol/therapeutic use , Humans , Leukocytes, Mononuclear/chemistry , Male , Neuropeptides/blood , Regression Analysis , Schizophrenia/blood , Schizophrenia/classification , Severity of Illness Index , Treatment Outcome , Vasoactive Intestinal Peptide/blood , Vasoactive Intestinal Peptide/drug effects , beta-Endorphin/blood , beta-Endorphin/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...